These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1584833)

  • 1. Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats.
    Castelló ME; Bolioli B; Dajas F
    Pharmacol Biochem Behav; 1992 Mar; 41(3):547-50. PubMed ID: 1584833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
    Kaneko M; Sato K; Horikoshi R; Yaginuma M; Yaginuma N; Shiragata M; Kumashiro H
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):53-7. PubMed ID: 1378633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract]   [Full Text] [Related]  

  • 4. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR; Emerich DF; el-Etri MM; Shipley MT; Zanol MD; Cahill DW; Norman AB
    Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cholinergic and non-cholinergic actions of acetylcholinesterase in the substantia nigra revealed by fasciculin-induced inhibition.
    Dajas F; Silveira R; Costa G; Castello ME; Jerusalinsky D; Medina J; Levesque D; Greenfield S
    Brain Res; 1993 Jul; 616(1-2):1-5. PubMed ID: 7689409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and behavioral correlates of unilateral striatal acetylcholinesterase inhibition by fasciculin in rats.
    Bolioli B; Castelló ME; Jerusalinsky D; Rubinstein M; Medina J; Dajas F
    Brain Res; 1989 Dec; 504(1):1-6. PubMed ID: 2598003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of local inhibition of locus coeruleus acetylcholinesterase by fasciculin in rats.
    Abó V; Viera L; Silveira R; Dajas F
    Neurosci Lett; 1989 Apr; 98(3):253-7. PubMed ID: 2471117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
    Jaskiw GE; Bongiovanni R
    Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat striatal acetylcholinesterase inhibition by fasciculin (a polypeptide from green mamba snake venom).
    Dajas F; Bolioli B; Castello ME; Silveira R
    Neurosci Lett; 1987 Jun; 77(1):87-91. PubMed ID: 3601220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats.
    Tucci S; Fernandez R; Baptista T; Murzi E; Hernandez L
    Brain Res Bull; 1994; 35(2):125-33. PubMed ID: 7953768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB; Rozitis A
    Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of ceruletide on haloperidol-induced catalepsy in rats.
    Ibii N; Ikeda M; Takahara Y; Eigyo M; Akiyoshi T; Matsushita A
    Peptides; 1989; 10(4):779-83. PubMed ID: 2587420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC; Delini-Stula AA
    Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.